MedTrace Logo

Cross Country Poling Specific Motor Skill- and Strength Training.

NCT03078673 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2021-09-27

No results posted yet for this study

Summary

Will motor skill- and/or strength training affect technique, work economy and time performance in cross-country poling? Competitive cross-country skiers (age 16- 30) will perform a 10 weeks training intervention. They will be randomized in one of the following three groups: poling specific motor skill training 3 times per week in addition to their regular training, maximal strength training 3 times per week in addition to their regular training and a control group who only perform their regular training. Pre- and post intervention, all participants will perform tests in VO2max (running), VO2max (poling), work economy (poling), video and inertial measurement unit (IMU) analyzes of poling technique, time performance test (poling), motor skill tests and maximal strength tests.

Conditions

  • Healthy

Interventions

OTHER

training intervention, motor skill training

cross country specific motor skill strength training

OTHER

training intervention, maximal strength training

general maximal strength training

OTHER

control group

regular training

Sponsors & Collaborators

  • The Norwegian Olympic Sports Center (Olympiatoppen)

    collaborator UNKNOWN

  • University of South-Eastern Norway

    lead OTHER

Principal Investigators

  • Arnstein Sunde, MSC · Telemark UC

  • Øyvind Støren, PhD · Telemark UC

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-20
Primary Completion
2019-04-01
Completion
2019-07-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03078673 on ClinicalTrials.gov